These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27403091)

  • 1. In vitro Quality of Platelets with Low Plasma Carryover Treated with Ultraviolet C Light for Pathogen Inactivation.
    Johnson L; Hyland R; Tan S; Tolksdorf F; Sumian C; Seltsam A; Marks D
    Transfus Med Hemother; 2016 May; 43(3):190-7. PubMed ID: 27403091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of refrigerated storage of UVC pathogen inactivated platelet concentrates on in vitro platelet quality parameters.
    Johnson L; Cameron M; Waters L; Padula MP; Marks DC
    Vox Sang; 2019 Jan; 114(1):47-56. PubMed ID: 30499111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of increased agitation speed on pathogen inactivation efficacy and in vitro quality in UVC-treated platelet concentrates.
    van der Meer PF; Gravemann U; de Korte D; Sumian C; Tolksdorf F; Müller TH; Seltsam A
    Vox Sang; 2016 Aug; 111(2):127-34. PubMed ID: 27167507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system - an update.
    Seghatchian J; Tolksdorf F
    Transfus Apher Sci; 2012 Apr; 46(2):221-9. PubMed ID: 22365926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method.
    Sandgren P; Tolksdorf F; Struff WG; Gulliksson H
    Vox Sang; 2011 Jul; 101(1):35-43. PubMed ID: 21175668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryopreservation of UVC pathogen-inactivated platelets.
    Waters L; Padula MP; Marks DC; Johnson L
    Transfusion; 2019 Jun; 59(6):2093-2102. PubMed ID: 30790288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of SARS-CoV-2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light.
    Hobson-Peters J; Amarilla AA; Rustanti L; Marks DC; Roulis E; Khromykh AA; Modhiran N; Watterson D; Reichenberg S; Tolksdorf F; Sumian C; Seltsam A; Gravemann U; Faddy HM
    Transfusion; 2023 Feb; 63(2):288-293. PubMed ID: 36573801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro function of platelets treated with ultraviolet C light for pathogen inactivation: a comparative study with nonirradiated and gamma-irradiated platelets.
    Tynngård N; Trinks M; Berlin G
    Transfusion; 2015 Jun; 55(6):1169-77. PubMed ID: 25524519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Watterson D; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Faddy HM
    Transfusion; 2017 Nov; 57(11):2677-2682. PubMed ID: 28718518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light.
    Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
    Vox Sang; 2020 Apr; 115(3):146-151. PubMed ID: 31930543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial inactivation of platelet concentrates with the THERAFLEX UV-Platelets pathogen inactivation system.
    Gravemann U; Handke W; Müller TH; Seltsam A
    Transfusion; 2019 Apr; 59(4):1324-1332. PubMed ID: 30588633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
    Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
    Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light.
    Rustanti L; Hobson-Peters J; Colmant AMG; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC; Faddy HM
    Transfusion; 2020 Nov; 60(11):2655-2660. PubMed ID: 32830340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA multiplex real-time polymerase chain reaction inhibition assay for quality control of pathogen inactivation by ultraviolet C light in platelet concentrates.
    Kim S; Handke W; Gravemann U; Döscher A; Brixner V; Müller TH; Seltsam A
    Transfusion; 2018 Mar; 58(3):758-765. PubMed ID: 29282743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively.
    Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
    Transfusion; 2018 Sep; 58(9):2202-2207. PubMed ID: 29732571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light.
    Praditya D; Friesland M; Gravemann U; Handke W; Todt D; Behrendt P; Müller TH; Steinmann E; Seltsam A
    Vox Sang; 2020 Oct; 115(7):555-561. PubMed ID: 32383163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover.
    Johnson L; Winter KM; Reid S; Hartkopf-Theis T; Marschner S; Goodrich RP; Marks DC
    Vox Sang; 2011 Oct; 101(3):208-14. PubMed ID: 21492184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogen inactivation of platelets using ultraviolet C light: effect on in vitro function and recovery and survival of platelets.
    Bashir S; Cookson P; Wiltshire M; Hawkins L; Sonoda L; Thomas S; Seltsam A; Tolksdorf F; Williamson LM; Cardigan R
    Transfusion; 2013 May; 53(5):990-1000. PubMed ID: 22905813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system.
    Johnson L; Loh YS; Kwok M; Marks DC
    Transfus Med; 2013 Apr; 23(2):121-9. PubMed ID: 23480103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light.
    Faddy HM; Fryk JJ; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC
    Transfusion; 2019 Jul; 59(7):2223-2227. PubMed ID: 31050821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.